On April 10, the U.S. Food and Drug Administration (FDA) issued an update on blood clots and birth control pills containing drospirenone. The update states that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. Read more and see a list of drospirenone-containing products here.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder